The novel therapy of this peptide represents a exciting breakthrough in the handling of the condition. Distinct from existing therapies, tirzepatide affects two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide922119.slypage.com/42578139/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment